Deans' stroke musings: Effect of cerebrolysin on motor function restoration during medical rehabilitation

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, November 22, 2019

Effect of cerebrolysin on motor function restoration during medical rehabilitation

Since it was successful in restoring motor function, HOW FUCKING LONG BEFORE IT GETS TO YOUR HOSPITAL? I'M GUESSING NEVER.

No one in your hospital is responsible for translating research into interventions. The board of directors and president need to be fired for such incompetence.

Earlier research here which I'm sure they did nothing on.

Cerebrolysin (5 post to November 2015)
Cerebrolysin® (1 post to June 2014)

Effect of cerebrolysin on motor function restoration during medical rehabilitation

Влияние церебролизина на восстановление двигательной функции в процессе медицинской реабилитации. Neurology, Neuropsychiatry, Psychosomatics , Volume 8(2) , Pgs. 80-86.

NARIC Accession Number: I245736. What's this?
Author(s): Kustova M.A.; Tolmachev A.P; Shamalov N.A.
Publication Year: 2016.
Abstract: This paper presents the January 2016 results of the randomized placebo-controlled multicenter study Cerebrolysin and Recovery After Stroke (CARS), which demonstrates the positive effect of cerebrolysin versus placebo according to the primary efficiency criterion, the Action Research Arm Test (ARAT) scale, and total outcome 90 days after disease onset. Ischemic stroke (IS) is characterized by high prevalence, mortality, and disability rates. Therapy aimed to correct one biochemical or molecular stage of ischemic cell injury fails to treat stroke, suggesting that it is necessary to study multimodality therapy affecting several related pathophysiological components. The CARS investigation enrolled mainly patients with moderate or severe IS (the mean National Institutes of Health Stroke Scale score was 9 at baseline). The specific features of the CARS study versus those of other clinical trials of neuroprotectors were the initial planning of narrower end criteria of efficiency (arm motor function recovery, whereas the major goal of many investigations was to reduce mortality rates), as well as a standardized rehabilitation program in both treatment groups. Such investigations did not previously consider the nature and volume of rehabilitation measures, although the latter may have a substantial impact on the outcome of stroke. The CARS study is the first among the previously conducted clinical trials of neuroprotectors that has attained the primary objective (to restore motor function), which presents fresh opportunities for the medical support of rehabilitation measures in patients with IS.
Descriptor Terms: Drugs, Rehabilitation, Stroke.
Language: Russian
Geographic Location(s): Europe, Russia.

Can this document be ordered through NARIC's document delivery service*?: Request Information.
Get this Document: https://nnp.ima-press.net/nnp/article/view/613/563.

Citation: Kustova M.A., Tolmachev A.P, Shamalov N.A. (2016). Effect of cerebrolysin on motor function restoration during medical rehabilitation. Влияние церебролизина на восстановление двигательной функции в процессе медицинской реабилитации. Neurology, Neuropsychiatry, Psychosomatics , 8(2), Pgs. 80-86. Retrieved 11/22/2019, from REHABDATA database.